In the context of ALL, increased CD58 expression on leukemic blasts could significantly impact their interaction with immune effector cells, potentially influencing immune surveillance and the ability of the immune system to eliminate malignant cells (26, 27). Here, CD58 is linked to acute lymphoblastic leukemia.